Details for New Drug Application (NDA): 084777
✉ Email this page to a colleague
NDA 084777 describes ARESTOCAINE HYDROCHLORIDE, which is a drug marketed by Solvay and is included in two NDAs. Additional details are available on the ARESTOCAINE HYDROCHLORIDE profile page.
The generic ingredient in ARESTOCAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
The generic ingredient in ARESTOCAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 084777
| Tradename: | ARESTOCAINE HYDROCHLORIDE |
| Applicant: | Solvay |
| Ingredient: | mepivacaine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084777
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3% | ||||
| Approval Date: | Apr 18, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
